Addex Therapeutics Ltd Stock Xetra
Equities
APE
CH0029850754
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | 10.75M 11.75M 10.99M | Capitalization | 14.81M 16.2M 15.15M |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.56M -6.14M | Net income 2025 * | - 0 0 | EV / Sales 2024 * | - |
Net cash position 2024 * | 362K 396K 371K | Net cash position 2025 * | 7.23M 7.9M 7.39M | EV / Sales 2025 * | 0.71 x |
P/E ratio 2024 * |
-1.28
x | P/E ratio 2025 * |
2.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.48% |
Latest transcript on Addex Therapeutics Ltd
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 17-05-31 |
Chairman | 75 | 09-04-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 54 | 18-05-31 |
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Chairman | 75 | 09-04-15 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |